BASF to increase 1,2-PDA capacity with new China plant

By Gareth Macdonald contact

- Last updated on GMT

BASF to increase 1,2-PDA capacity with new China plant

Related tags: Active pharmaceutical ingredients, Manufacturing

BASF has announced plans for a specialty amines plant at its site on the Nanjing Chemical Industry Park in China, citing increasing demand from customers in Asia.

The plan – which is due to be operational in 2019 – will make a range of amines including 1,2-Propylenediamine (1,2-PDA), which is used as a building block in the manufacture of a wide range of active pharmaceutical ingredients (API).

Narayan Krishnamohan, senior VP of BASF’s intermediates business in Asia Pacific, said: “This investment will help us to meet the increasing Asia Pacific demand for specialty amines used as intermediates in a diverse range of industries and applications.”

Related news

Show more

Related products

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

SQ-USP-Brochure-Thumb-AP-CC

NEW…sugarcane derived USP Squalane from Aprinnova

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Related suppliers